Inconsistent methods and the lack of granularity in assessing the intensity of ER have offered as potential explanations for the inconsistent results of different studies, such as biomarker studies of the hormonal therapy based on ER expression in ovarian cancer [58, 59]. This evidence concerns the gene ESR1 and ovarian cancer.